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HSV-2 infection-induced CXCR3 ligands are important for the recruitment of
virus-specific CD8+ T cells, but their impact on CD4+ T cell trafficking remains to be
further determined. Given that recruitment of CD4+ T cells to infection areas may be one
of the mechanisms that account for HSV-2 infection-mediated enhancement of HIV-1
sexual transmission, here we investigated the functionality of HSV-2 infection-induced
CXCR3 ligands CXCL9, CXCL10, and CXCL11 in vivo and in vitro, and determined
the viral components responsive for such induction and the underlying mechanisms.
We first found that the expression of CXCR3 ligands CXCL9, CXCL10, and CXCL11
was increased in mice following vaginal challenge with HSV-2, while CXCL9 played
a predominant role in the recruitment of CD4+ T cells to the vaginal foci of infected
mice. HSV-2 infection also induced the production of CXCL9, CXCL10, and CXCL11
in human cervical epithelial cells. Of note, although HSV-2 induced the expression of
all the three CXCR3 ligands, the induced CXCL9 appeared to play a predominant role
in promoting CD4+ T cell migration, reflecting that the concentrations of CXCL10 and
CXCL11 required for CD4+ T cell migration are higher than that of CXCL9. We further
revealed that, ICP4, an immediate-early protein of HSV-2, is crucial in promoting CXCR3
ligand expression through the activation of p38 MAPK pathway. Mechanistically, ICP4
binds to corresponding promoters of CXCR3 ligands via interacting with the TATA binding
protein (TBP), resulting in the transcriptional activation of the corresponding promoters.
Taken together, our study highlights HSV-2 ICP4 as a vital viral protein in promoting
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CXCR3 ligand expression and CXCL9 as the key induced chemokine in mediating CD4+
T cell migration. Findings in this study have shed light on HSV-2 induced leukocyte
recruitment which may be important for understanding HSV-2 infection-enhanced HIV-1
sexual transmission and the development of intervention strategies.
Keywords: HSV-2, CXCR3 ligands, CD4+ T cells, recruitment, ICP4
INTRODUCTION
Herpes simplex virus type 2 (HSV-2), a large enveloped dsDNA
virus, affects ∼500 million people worldwide and acquires an
annual rate of close to 25 million (1), resulting in up to
40% human adults living with HSV-2 latency (2, 3). HSV-2
infections are known to be restricted to mucosal and keratinized
epithelia and neuronal ganglia, and cause genital herpes (4)
with sexual transmission being the main route (5). Human
immunodeficiency virus type 1 (HIV-1) causes destruction of
the immune system, leading to acquired immune deficiency
syndrome (AIDS) (6). In 2016, there were 1.8 million new HIV-1
infections globally, adding up to a total of 36.7 million people
living with HIV-1 (7). The majority of HIV-1 infections are
acquired by genital mucosal exposure, with sexual transmission
as the leading mode of HIV-1 infection worldwide (8).
Due to the high positive-incidence of HSV-2 and common
routes of transmission with HIV-1, mucosal HIV-1/HSV-2 co-
infections attract more and more attention. Epidemiological
studies show that HSV-2 infection results in an∼3-fold increased
risk of HIV-1 acquisition (9, 10), but the underlying mechanisms
remain to be determined. One of the mechanisms that HSV-2
infection increases the probability of HIV-1 acquisition is the
generation of lesions at HSV-2-infection sites, which provides
a chance for HIV-1 to contact the target cells in the epidermis
and dermis (11). Moreover, the number of CD4+ T cells at
the infection sites is increased following HSV-2 infection, which
may further facilitate HIV-1 to infect these target cells (12–14).
However, it is still not fully elucidated concerning the mechanism
of CD4+ T cell migration induced by HSV-2.
Chemokine CXCL9 is a member of the CXC family and
plays an important role in the chemotaxis of CXCR3+ immune
cells. CXCR3 is a chemokine receptor that is rapidly induced on
activated naive cells and sustains highly expression on Th1-type
CD4+ T cells and effector CD8+ T cells (15). CXCR3 could be
activated by three interferon-inducible ligands CXCL9 (MIG),
CXCL10 (IP-10), and CXCL11 (I-TAC). Although CXCR3
could also be activated by CXCL4 and CXCL4L1, these two
chemokines are released by platelets and have been implicated
in atherogenesis and acute coronary syndrome (16). It is known
that the upregulation of CXCR3 ligands is positively associated
Abbreviations: HSV-2, herpes simplex virus type 2; HIV-1, human
immunodeficiency virus type 1; AIDS, acquired immune deficiency syndrome;
PBMC, peripheral blood monocyte cell; C/EBP-β, CCAAT/enhancer-binding
protein-β; MIG, monokine induced by gamma-interferon; IP-10, interferon-
induced protein-10; I-TAC, interferon-inducible T-cell alpha chemoattractant;
TFIIB, transcription factor II B; TBP, TATA binding protein; TFIID, transcription
factor II D; Ultraviolet, UV.
with a variety of tumors, inflammatory diseases, and infectious
diseases such as AIDS (17). Although the expression of CXCL9
and CXCL10 has been shown to be increased in the cervical
tissues of mice infected by HSV-2, the study on mice focused on
the roles of recruited CD8+ T cells in control of HSV-2 infection
(18–20). Our previous study demonstrated that CXCL9 levels in
cervical mucus from HSV-2–positive women were significantly
increased and that CXCL9 induced by HSV-2 infection in
cervical epithelial cells can enhance the migration of CD4+
T cells (14). Although HSV-2-induced expression of CXCL10
and CXCL11 was previously reported (19, 21), the significance
of HSV-2-induced CXCR3 ligands in vivo and the molecular
mechanisms underlying the HSV-2-induced expression of
CXCR3 ligands, in particular CXCL10 and CXCL11, have yet to
be addressed. Furthermore, HSV-2 component(s) responsible for
the induction and the underlying mechanism remain to be fully
investigated.
In the current study, we found that expression of mouse
CXCR3 ligands was increased following vaginal challenge with
HSV-2 in mice. In addition, HSV-2-induced CXCL9 played a
crucial role in promoting CD4+ T cell migration to the vaginal
foci of infected mice. In human cervical epithelial cells, HSV-
2 infection induced the production of CXCL10 and CXCL11
in addition to CXCL9. Although CXCL10 and CXCL11 were
induced following HSV-2 infection, the migration of CD4+ T
cells was mainly dependent on HSV-2 infection-induced CXCL9,
reflecting that the concentrations of CXCL10 and CXCL11
required for CD4+ T cell migration are higher than that of
CXCL9. Moreover, HSV-2 immediate-early protein ICP4 (also
known as RS1) appeared to be the vital viral component to
induce the production of CXCR3 ligands. We further explored
the molecular mechanisms underlying ICP4–induced CXCR3
ligand expression, revealing that ICP4 binds to corresponding
promoters of CXCR3 ligands to activate their transcription by
interaction with TBP. Our study together has shed light on
the molecular mechanisms underlying HSV-2-induced CD4+
T cell accumulation in mucosal infection sites, which may
be crucial for understanding HSV-2 infection-enhanced HIV-
1 sexual transmission and the development of intervention
strategies.
MATERIALS AND METHODS
Viruses, Cell Lines, Antibodies, and
Inhibitors
HSV-2 (G strain) was obtained from LGC standards and
propagated in African green monkey kidney cells (Vero).
Virus stocks were aliquoted and stored at −80◦C before
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used for infection. Ultraviolet (UV)-inactivated HSV-2 was
obtained by exposure to ultraviolet irradiation for 15min. HSV-
2 titration was determined by plaque assay on confluent Vero
monolayers (53). ME180, PM1, and Vero cells were obtained
from American Tissue Culture Collection. Human cervical
epithelial cell line ME180 and Vero cells were cultured in
Dulbecco’s modified Eagle medium (DMEM) (Life Technologies,
11965, Australia) supplemented with 10% FBS, 100 units/mL
penicillin and 100 units/mL streptomycin at 37◦C in a 5% CO2
incubator. Human T cell line PM1 cells were cultured in RPMI-
1640 medium (HyClone, SH30809.01B, USA) supplemented
with 10% FBS, 100 units/mL penicillin and 100 units/mL
streptomycin at 37◦C in a 5% CO2 incubator. Abs against
p38, phospho-p38, and β-actin, respectively, were purchased
from Santa Cruz Biotechnology (sc-7149, sc-101759 and sc-
81178, USA). Ab against phospho-C/EBP-β was purchased from
Cell Signaling Technology (3084S, USA). Inhibitors specifically
against ERK (PD98059), JNK (SP600125), and p38 (SB203580),
respectively, were purchased from Merck Millipore (19-143,
420119, and 559389, USA). Abs against HA and Flag tag
were purchased from Sigma-Aldrich (H6908 and F1804, USA).
Ab against Proliferating Cell Nuclear Antigen (PCNA) and
TATA binding protein (TBP) were from Proteintech (10205-
2-AP and 22006-1-AP, Wuhan, China). Rabbit normal IgG
and Cy3-conjugated goat anti-mouse IgG were purchased from
BOSTER (BA1031 and BA1045, Wuhan, China). Abs against
mouse CD4, CXCL9, CXCL10, and CXCL11 were purchased
from R&D Systems (MAB554, AF-492-NA, AF-466-NA, and
AF-572, USA). Abs against ICP4, ICP27, gB, and HSV-2
were from Abcam (ab96431, ab53480, ab6506, and ab21112,
England). Ab against gD was from Santa Cruz Biotechnology
(sc-69802, USA).
Plasmid Construction
HSV-2 genome was extracted from the cells infected with
HSV-2 for 48 h using QIAamp DNA Blood Mini Kit (Qiagen,
51104, Germany). The expression plasmids of US1, RS1, US12,
UL54, and RL2, and the reporter of CXCL9 were described
previously (14, 22). The open reading frames (ORFs) were
amplified by PCR with the primers shown in Table S1. The
reporters of CXCL10 and CXCL11 were amplified with forward
primers (CXCL10 Luc-F and CXCL11 Luc-F) and reverse
primers (CXCL10 Luc-R and CXCL11 Luc-R), respectively. The
sequences of primers were showed in Table S1. An N-terminal
HA or Flag tag was introduced into ICP4 by the forward
primer. N-terminal Flag tag was introduced into UL20, UL46,
UL47, UL48, UL56, UL49A, US4, US7, or RL1 by the forward
primer. The promoter reporters were cloned into pGL3-basic.
Unless otherwise described, other PCR products were cloned
into pcDNA3.1(+) (Invitrogen) and the constructed expression
plasmids were named UL20, RS1-HA (ICP4-HA), RS1-Flag
(ICP4-Flag), UL46, UL47, UL48, UL56, UL49A, US4, US7,
RL1, UL20-Flag, UL46-Flag, UL47-Flag, UL48-Flag, UL56-Flag,
UL49A-Flag, US4-Flag, US7-Flag, and RL1-Flag, respectively.
The constructs were verified by DNA sequencing (Sunny
Biotechnology, Shanghai, China).
HSV-2 Challenge and Sampling
Animal experiments were approved by the Institutional Animal
Care and Use Committee and performed in accordance with the
guidelines of the Hubei Laboratory Animal Science Association.
In brief, female BALB/c mice (6–8 wk old) were purchased from
Beijing HFK Biotechnology (Beijing, China) and maintained
in specific pathogen–free conditions with food and water
supplied. Seven days prior to challenge, each mouse was injected
with 2mg progesterone in intraperitoneal, subcutaneous, and
intramuscular sites to ensure that each mouse rapidly entered
the estrous cycle (23). After the estrous cycle, the mouse vaginal
mucosal epithelia became thinner and were more susceptible
to HSV-2. One day prior to challenge, the neutralizing Abs
against CXCL9 (2 µg, R&D Systems, MAB554, USA), CXCL10
(2 µg, R&D Systems, MAB554, USA), and CXCL11 (2 µg,
R&D Systems, MAB554, USA) were delivered to the vagina of
mice, respectively, or in combination. Mice were anesthetized
with pentobarbital sodium and challenged intravaginally with 10
µL/mouse HSV-2 at a concentration of 6 × 107 PFU/mL. Mice
challenged with medium alone were set as background controls.
The signs of mouse vagina were observed at days 3, 5, and 7
post HSV-2 challenge. Vaginal ulcers arose at day 7 in infected
mice but not in the control group. Seven days after challenge,
vaginal lavage fluids were collected using a vaginal Transferpettor
by washing the vagina three times with sterile PBS plus protease
inhibitors (Roche, 11697498001, Germany) in a total volume
of 100 µL/mouse. Collected samples were centrifuged (15,000
× g, 10min at 4◦C), and supernatants were aliquoted and
stored at −80◦C until use. Thereafter, mice were sacrificed
by neck dislocation. The cervical-vaginal tissues (Y type, two
fallopian tube in the upper and vagina in the lower) were excised
according to the characteristics of mouse physiological structure
and collected under sterile conditions. The tissues were fixed in
4% formaldehyde followed by immunohistochemistry analysis.
The collection of vaginal lavages or tissues was performed by the
same people.
CBA for Human CXCL9, CXCL10 and
CXCL11, and Mouse CXCL9 and CXCL10
ME180 cells in 6-well plates were transfected with empty vector
or plasmid expressing ICP4 for 24 h. In some cases, ME180
cells were infected or mock-infected with HSV-2 for 24 h.
Cell supernatants were collected and centrifuged to remove
cell debris. Cytometric Bead Assay (CBA) was carried out to
quantify secreted human CXCL9, CXCL10, and CXCL11 using
the BD Cytometric Bead Array Human Soluble Protein Flexset
Kit according to the manufacturer’s instructions. Briefly, 50 µL
diluted standards or undiluted samples were added into labeled
tubes followed by the addition of 50 µL mixed beads. At 1 h post-
incubation, 50 µL PE conjugated detection antibody was added
into all tubes followed by incubation for 2 h at room temperature.
All tubes were then washed with 1mL washing buffer and
centrifuged at 1,200 rpm for 5min. The supernatants were
removed and the beads were resuspended with 300 µL washing
buffer. The concentration of mouse CXCL9 and CXCL10 in
the vaginal lavage fluids was detected using the LEGENDplexTM
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Cytometric Bead Array mouse proinflammation Chemokine
Mix and Match Subpanel according to the manufacturer’s
instructions. Briefly, 25 µL assay buffer was added into all tubes,
followed by the addition of 25 µL diluted standard or 25 µL
undiluted sample to each labeled tube. Thereafter, 25 µL mixed
beads and 25 µL detection antibodies were added into all tubes
followed by incubation for 2 h at room temperature with shaking.
All the tubes were then incubated for 30min at room temperature
after the addition of 25 µL SA-PE solution. Beads were spun
down (1,100 rpm, 5min at room temperature) and washed with
1× washing buffer. The beads were resuspended with 200 µL
of 1× washing buffer. All the samples were read on the BD
LSRFortessaTM Flow Cytometer.
ELISA for Mouse CXCL11
The concentration of CXCL11 in the vaginal lavage fluids of
mice was detected using Mouse CXCL11 ELISA Kit (BOSTER,
EK0738, China). The standard of CXCL11 was provided in the
Kit. Fifty microliter of undiluted fluids were tested for mouse
CXCL11 detection according to the manufacturer’s instructions.
Immunohistochemistry
Immunohistochemistry analysis of mouse cervical-vaginal
tissues was conducted as described previously (24, 25). Briefly,
the specimens obtained from challenged mice were fixed in
4% formaldehyde for 24 h at room temperature, embedded
in paraffin, and cut into 3-mm sections. For detection of
CD4+ T cells in cervical-vaginal samples, slides were first
dewaxed in xylene and rehydrated in a descendant ethanol
scale. Ag retrieval was subsequently performed using Antigen
Retrieval Reagent Basic Kit (R&D Systems, CTS013, USA)
for 30min in a water bath according to the manufacturer’s
instructions, and endogenous peroxidase was blocked by 3%
H2O2 for 10min at room temperature. Immunohistochemistry
staining was performed using Cell & Tissue Staining Kit
(R&D Systems, CTS017, USA) according to the manufacturer’s
instructions. CD4+ T cells were detected by rabbit anti-mouse
CD4 Ab. HSV-2 infection was detected by goat anti-HSV-2
polyclonal Ab. The colorimetric reaction was developed by
adding 3, 3′-diaminobenzidine (DAB) at room temperature.
For immunofluorescence detection of ICP4 and CXCR3 ligands
or HSV-2 in cervical-vaginal samples, slides were first treated
as the above instruction. ICP4 was detected with rabbit anti
HSV-2 ICP4 Ab. Mouse CXCL9, CXCL10, and CXCL11 were
detected by goat anti-mouse CXCL9, CXCL10, and CXCL11 Abs,
respectively. HSV-2 was detected by goat anti-HSV-2 polyclonal
Ab. FITC-conjugated goat anti-mouse, Cy3 conjugated donkey
anti-goat and anti-rabbit (Beyotime, A0568, A0502, and A0516,
China) secondary Abs were used in subsequent detection. The
images were acquired using the Hungary 3DHISTECH apparatus
(Pannoramic MIDI).
Dual Luciferase Report (DLR) Assay
ME180 cells were seeded in 24-well plates overnight and co-
transfected with empty vector or plasmid encoding ICP4,
Renilla luciferase plasmid phRL-TK and reporter plasmid
CXCL9-Luc, CXCL10-Luc or CXCL11-Luc. Transfections were
carried out using X-tremeGENETM HP DNA Transfection
Reagent (Roche, 6366236001, Germany) according to the
manufacturer’s instructions. At 24 h post-transfection, cells were
harvested and lysed. The lysates were used for measuring
firefly and Renilla luciferase activities using the Dual-Luciferase
Reporter Assay System (Promega, E1980, USA) according to
the manufacturer’s instructions. For some experiments, ME180
cells were co-transfected with reporter plasmid CXCL9-Luc,
CXCL10-Luc or CXCL11-Luc, and phRL-TK, followed by
infection with HSV-2 or ultraviolet-inactivated HSV-2 at an
MOI of 1. At 24 h post-infection, the enzymatic activities
of Firefly and Renilla luciferase were measured. Values for
the samples were normalized using Renilla luciferase values
and expressed as fold increase of the value induced in
cells transfected with empty vector or mock-infected with
DMEM.
RNA Isolation and Quantitative PCR
Cells were collected and total RNA was extracted using
RNA isolation kit (MN, 740955, Germany) according to the
manufacturer’s instructions. The cDNA was synthesized by
Moloney murine leukemia virus transcriptase (Promega, M170B,
USA). The newly synthesized cDNA was used as the template for
amplifying the genes of CXCR3 ligands and GAPDH. The primer
pairs for CXCL9, CXCL10, and CXCL11 were named CXCL9-
F/CXCL9-R, CXCL10-F/CXCL10-R, and CXCL11-F/CXCL11-
R (Table S1). GAPDH was used as an internal control and
amplified with primers GAPDH-F and GAPDH-R (Table S1).
Relative real-time quantitative PCR was performed on an ABI
StepOne apparatus using a SYBR Green Real-Time PCR Master
Mix (Toyobo, QPK-201, Japan) according to the following
conditions: 95◦C for 1min, followed by 40 cycles of 95◦C for 15 s,
60◦C for 15 s, and 72◦C for 45 s. The expression difference was
calculated on the basis of 2−11Ct values.
Western Blot
Western blot analysis was performed as described previously
(22). Briefly, cytoplasmic and nuclear proteins were isolated
using the Nucleus and Cytoplasm Protein Extraction Kit
(Beyotime, P0028, China). In some cases, cells were lysed
with lysis buffer (Life technologies, 87788, USA). Cell extracts
were subjected to 10 or 15% SDS-PAGE and transferred onto
PVDF membranes (Millipore 0.45µm or 0.22µm) followed by
blocking with 5% non-fat milk in Tris-buffered saline-Tween
(TBST, 50mM Tris-HCl pH 7.5, 200mM NaCl, 0.1% (v/v)
Tween-20) at room temperature for 2 h. The membrane was
clipped according to the molecular weight of the protein, and
then probed with an appropriate primary antibody at room
temperature for 2 h. After three washes with TBST, themembrane
was incubated with horseradish peroxidase (HRP)-conjugated
goat anti-rabbit IgG (BOSTER, BA1054, China), goat anti-
mouse IgG (BOSTER, BA1051, China) or donkey anti-goat IgG
(Beyotime, A0181, China) at room temperature for 1 h. Protein
bands were visualized by exposure to FluorChem HD2 Imaging
System (Alpha Innotech) after the addition of chemiluminescent
substrate (Beyotime, P0018, China). Protein molecular weight
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markers were purchased from Thermo Fisher (26616, USA) and
YEASEN (20352, China).
Isolation and Culture of PBMCs and CD4+
T Cells
All protocols involving human subjects were reviewed and
approved by the local Research Ethics Committee of Wuhan
Institute of Virology, Chinese Academy of Sciences. Informed
written consents from the human subjects were obtained in
this study. Both sexes were used and the donors were free of
HSV-1 and HSV-2. PBMCs were isolated from healthy donors
by using a Ficoll-Hypaque density gradient. CD4+ T cells were
separated from PBMCs using CD4+ Cell Negative Isolation Kit
according to the manufacturer’s protocol (Miltenyi Biotec, 130-
096-533, Germany). PBMCs and CD4+ T cells were activated
by stimulating with 1µg/mL PHA (Sigma-Aldrich, L4144, USA)
and 20 U/mL IL-2 (PeproTech, 200-02, USA). PBMCs and CD4+
T cells cultured in complete RPMI 1640 containing 20 U/mL IL-
2 were used as controls for flow cytometry. PBMCs and CD4+ T
cells were harvested at day 7 and used in subsequent assays.
Chemotaxis Assay
Chemotaxis assay was performed using 24-well Transwell plates
(Costar, 3415, USA). One milliliter supernatants from ME180
cells which were mock-infected or infected with HSV-2, or mock-
transfected or transfected with ICP4 expressing plasmid were
added to the lower chamber. To examine the roles of CXCR3
and CXCR3 ligands in mediating cell migration, supernatants or
cells were incubated with anti-CXCL9 (10µg/mL, R&D Systems,
MAB392, USA), -CXCL10 (2µg/mL, R&D Systems, MAB266,
USA), -CXCL11 (2µg/mL, R&D Systems, MAB672, USA) or -
CXCR3 (1µg/mL, R&D Systems, MAB160, USA) neutralizing
Abs, respectively, for 1 h, according to the manufacturer’s
instructions. Activated PBMCs and CD4+ T cells (5× 105) in 100
µL RPMI-1640 medium were added to the upper chamber. The
chambers were incubated for 2 h at 37◦C in a 5% CO2 incubator.
Cell migrated to the lower chambers were collected and counted
using an automatic cell counter (Bio-Rad).
Flow Cytometry
PBMCs and CD4+ T cells were collected and resuspended
with 3% FBS on ice for 10min. Hundred microliter cell
suspension (1 × 106) was prepared for one test. Two microliter
BV421 conjugated mouse anti-human CD25 (BD biosciences,
562443, USA), BB515 conjugated mouse anti-human CD4
(BD biosciences, 564419, USA) and APC conjugated mouse
anti-human CD69 (BD biosciences, 560967, USA) Abs or PE
conjugated mouse anti-human CXCR3 Ab (BD biosciences,
560928, USA) were added into the corresponding samples,
followed by incubation on ice for 15min. Background staining
was assessed by isotype-matched control Abs, including BV421
conjugated mouse IgG1 (BD biosciences, 562438, USA), BB515
conjugated mouse IgG1 (BD biosciences, 564416, USA), APC
conjugated mouse IgG1 (BD biosciences, 555751, USA), and
PE conjugated mouse IgG1 (BD biosciences, 555749, USA).
Cells were washed with 1× PBS for three times. Three
hundred microliter cell suspension was filtrated through a 200-
mesh membrane and performed on BD LSRFortessaTM Flow
Cytometer. Data were analyzed using BD FACSDiva software
(BD Biosciences).
Immunofluorescence Assay
ME180 cells were seeded in 35-mm dishes with glass bottom and
transfected with HA-tagged plasmid expressing ICP4. At 24 h
post-transfection, cells were fixed with 4% formaldehyde and
permeabilized with 0.2% Triton X-100. After three washes with
1× PBS, cells were blocked in PBS containing 5% BSA at 4◦C
overnight. Thereafter, cells were incubated with mouse anti-HA
Ab at a dilution of 1:100 at 37◦C for 1 h. Following three washes
with 1× PBS, cells were then incubated with Cy3-conjugated goat
anti-mouse IgG (Beyotime, A0521, China) at a dilution of 1:50 for
1 h at 37◦C. Cells were subsequently washed and incubated with
DAPI for 10min at 37◦C. After washes, cells were incubated with
anti-fluorescence quenching reagent (Beyotime, P0126, China)
and observed under a fluorescence microscope (Olympus IX51).
Chromatin Immunoprecipitation (ChIP)
ME180 cells in 6-well plates were transfected with HA-tagged
plasmid expressing ICP4 or empty vector. At 24 h post-
transfection, ChIP assay was performed as described previously
(22) according to the manufacturer’s instructions (Millipore,
17-409, Germany). The purified DNA was used as a template
for PCR detection of the promoter sequences of CXCR3
ligands with primer pairs CXCL9 pro-F/CXCL9 pro-R, CXCL10
pro-F/CXCL10 pro-R, and CXCL11 pro-F/CXCL11 pro-R,
respectively (Table S1).
Co-immunoprecipitation (Co-IP) Assay
ME180 cells in 6-well plates were transfected with HA-tagged
ICP4 expression plasmid or empty vector. At 24 h post-
transfection, cells were harvested and lysed on ice for 10min
in 200 µL of lysis buffer (50Mm Tris (PH 8.0), 150mM
NaCl, 1% NP40) containing protease inhibitor cocktail (Roche,
11697498001, Germany). To eliminate nonspecific binding of
other proteins, the samples were pretreated with dynabeads
Protein G (Invitrogen, 10003D, USA) for 2 h at room temperature
followed by separation prior to Co-IP assay. Meanwhile, 2 µg
rabbit anti-HA Ab or control rabbit Ab was diluted in 200 µL
PBS with 1% Tween-20 (PBST) and added to fresh dynabeads
protein G. After incubation with rotation for overnight at 4◦C,
dynabeads-Ab complexes were washed once with 200 µL PBST
before mixed with the pretreated samples, followed by overnight
incubation with rotation at 4◦C to allow the formation of
dynabeads-Ab-Ag complexes. The complexes were washed three
times with PBST and target antigens were eluted by boiling and
subjected to western blot analysis.
Statistical Analysis
All experiments were repeated at least three times and the data
are presented as mean ± S.D. with each condition performed in
triplicate or in duplicate unless otherwise specified. Data analyses
were performed with GraphPad Prism 5 software (GraphPad).
Comparison between two groups was analyzed by two tailed
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FIGURE 1 | Contribution of HSV-2 infection-induced CXCR3 ligands to CD4+ T cell infiltration into mouse vagina. Seven days prior to HSV-2 challenge, BALB/c mice
were injected with progesterone in multiple sites. One day prior to HSV-2 challenge, CXCL9, CXCL10, and CXCL11 neutralizing antibodies were delivered to the
vagina of mice, alone or in combination, while isotype matched control IgG was used as the control. Mice were then anesthetized with pentobarbital sodium and
challenged intravaginally with 10 µL/ mouse HSV-2 at a concentration of 6 × 107 PFU/ml or mock- challenged. Vaginal lavage fluids and cervical-vaginal tissues were
collected at day 7 after challenge. (A) HSV-2 infection induces the production of mouse CXCR3 ligands. The protein levels of CXCL9 and CXCL10 ligands in vaginal
lavage fluids were measured by CBA, and the protein level of CXCL11 was detected by ELISA. (B) CXCL9 mediates the migration of CD4+ T cells to the vaginal foci
of infected mice. CD4+ T cells in infection foci were detected using anti-CD4 Ab by IHC. The scale bar indicates 100µm. Data shown are mean ± S.D. (n = 5
mice/group) of three independent experiments (A). ***p < 0.001. One representative out of three independent experiments is shown (B).
unpaired Student’s t-test, whereas comparisons amongmore than
two groups were analyzed by one-way ANOVA with the Turkey’s
test. P < 0.05 was considered statistically significant.
RESULTS
Contribution of HSV-2 Infection-induced
CXCR3 Ligands to CD4+ T Cell Infiltration
Into Mouse Vagina
The expression of CXCL9 and CXCL10 has been shown to
be increased in the cervical tissues of mice infected by HSV-
2 in previous studies (20), which mainly focused on the
recruitment of activated CD8+ T cells and its contribution to
the control of HSV-2 infection. However, the impact of HSV-
2 infection on CD4+ T cell migration in mice remains to be
further addressed. To assess this, mice were challenged with
HSV-2 vaginally, and vaginal lavage fluids and cervical-vaginal
tissues of the mice were collected for subsequent assessment.
We confirmed a productive infection of HSV-2 in mouse
vagina by immunohistochemistry and immunofluorescence-
histochemistry assays (Supplementary Material Figures 1A,B),
while Cytometric Bead Array (CBA) showed that the production
of mouse chemokines CXCL9 and CXCL10 was significantly
increased (Figure 1A). ELISA also indicated the enhancement
of CXCL11 in mice challenged with HSV-2 (Figure 1A).
Meanwhile, immunohistochemistry (IHC) assays showed that
the number of CD4+ T cells was significantly increased in the
vaginal foci of infected mice (Figure 1B). To identify which
chemokine plays a vital role in CD4+ T cell recruitment,
mice were vaginally treated with the neutralizing Ab against
CXCL9, CXCL10, or/and CXCL11 before HSV-2 challenge.
The number of CD4+ T cells was dramatically decreased
after the administration of CXCL9 neutralizing antibody to
the vagina of mice (Figure 1B). Although the migration
of CD4+ T cells was almost completely abolished after
administration of a combination of neutralizing Abs against
CXCL9, CXCL10, and CXCL11 into the vaginal tissue, CD4+
T cells were still significantly recruited to the infection foci
after the administration of CXCL10 or CXCL11 neutralizing
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antibody (Figure 1B). These data together indicate that HSV-
2 vaginal infection of mice increases the expression of CXCR3
ligands CXCL9, CXCL10 and CXCL11, and the migration
of CD4+ T cells to the vaginal foci is mainly mediated by
CXCL9.
HSV-2 Infection Induces the Production of
CXCR3 Ligands in Human Cervical
Epithelial Cells
Although HSV-2-induced expression of CXCL10 and CXCL11
was previously reported (19, 21), it remains to be addressed as
to how HSV-2 induces the expression CXCR3 ligands in human
mucosal epithelial cells. Epithelial cells are the primary HSV-2
target cells during sexual transmission. Having demonstrating
the correlation of CXCR3 ligands with CD4+ T cell migration
in mice, we next addressed the underlying mechanism in cellular
models. Our previous study showed that HSV-2 infection of
human epithelial cells induces CXCL9 expression (14). To
investigate the association between HSV-2 infection and the
induction of CXCR3 ligands, human cervical epithelial cell line
ME180 was used for assessing CXCR3 ligand expression at
promoter, mRNA and protein levels. Our results indicated that
HSV-2 infection significantly activated not only the promoter
of CXCL9 but also the promoters of CXCL10 and CXCL11
(Figure 2A). We next assessed whether HSV-2 productive
infection is necessary for the transcriptional activation of CXCR3
ligands. The results showed that UV-inactivated HSV-2 did not
significantly induce the transcriptional activation of CXCL9 and
CXCL10. Although CXCL11 appeared to be induced by UV-
inactivated HSV-2, the level of induction was low (Figure 2A).
In agreement, several HSV-2 proteins were undetectable
following UV inactivation (Supplementary Material Figure 2).
These results together indicated that HSV-2 productive infection
is essential for the induced production of CXCR3 ligands. To
further confirm the effect of HSV-2 on the induction of CXCL10
and CXCL11, we next investigated the mRNA and protein levels
of CXCL10 and CXCL11 following HSV-2 infection. Relative
real-time PCR assay and CBA showed that HSV-2 infection
significantly promoted the production of CXCL9, CXCL10,
and CXCL11 at both mRNA (Figure 2B) and protein levels
(Figure 2C).
HSV-2 Infection-induced CXCL9 Plays a
Predominant Role in Mediating CD4+ T
Cell Migration
It is known that CXCR3 is highly expressed on CD4+ T cells
and CXCL9, CXCL10 or CXCL11 could activate CXCR3+ T cells
(15). We previously demonstrated the functionality of HSV-2-
induced CXCL9 in chemotacting CD4+ T cells (14). To assess the
functionality of HSV-2–induced CXCL10 and CXCL11 in human
cells, chemotaxis assay was performed using activated human
peripheral blood mononuclear cells (PBMCs) and CD4+ T cells.
The percentage of CD4+ cells was 95.6 and 33.4% in CD4+ T cells
and PBMCs, respectively (Supplementary Material Figure 3).
We also confirmed that CD4+ T cells and PBMCs were
activated by PHA prior to the onset of chemotaxis assay
(Supplementary Material Figure 4). ME180 cells were infected
with HSV-2 for 24 h, and the chemotactic activity of supernatants
was determined. In response to supernatants from HSV-2–
infected cells, the migratory activity of PBMCs (Figure 3B)
and CD4+ T cells (Figure 3C) was significantly increased. Cell
migration was almost abolished upon the addition of anti-
CXCL9 neutralizing Ab to supernatants from HSV-2–infected
cells (Figures 3B,C), whereas a control Ab, anti-CXCL10 or
CXCL11 neutralizing Ab did not have such effect, which is
accordance with a previous study (26), indicating the critical role
of CXCL9 in inducing CD4+ T cell migration. To further confirm
the observation, a neutralizing Ab against CXCR3 was mixed
well with cells for 1 h and then added into the upper chamber
in chemotaxis assay, showing that the migration of CD4+ T cells
was significantly reduced (Figure 3D). We also demonstrated
that HSV-2 infection did not regulate the expression of CXCR3 by
flow cytometry assay (Supplementary Material Figure 5A).The
concentrations of CXCL9, CXCL10, and CXCL11 in the
supernatants of HSV-2-infected ME180 cells used for chemotaxis
assays were detected by CBA (Figure 3A), showing that CXCL10
and CXCL11 were produced at levels not less than that of CXCL9.
We therefore conducted the chemotaxis assay using recombinant
CXCL9, CXCL10, or CXCL11 at the similar concentration as
that induced by HSV-2 infection. The results indicated that
recombinant CXCL9 induced the migration of CD4+ T cells
at a low concentration of 48 pg/ml, whereas CXCL10 and
CXCL11 had no significant impact on CD4+ T cell migration
at the concentrations of 55 pg/mL and 175 pg/mL, respectively
(Figure 3E). Nevertheless, CXCL10 or CXCL11, at a much
higher concentration than that induced by HSV-2 infection,
did promote the migration of CD4+ T cells (Figures 3F,G),
indicating that the concentrations of CXCL10 and CXCL11
required for CD4+ T cell migration are higher than that of
CXCL9. Taken together, our results together indicated that HSV-
2 infection-induced CXCL9 likely plays a predominant role in
mediating CD4+ T cell migration.
HSV-2 ICP4 Promotes the Production of
Human CXCR3 Ligands
UV-inactivation attenuated the ability of HSV-2 to induce
CXCR3 ligand production, indicating that productive HSV-2
infection is necessary for the induced production of CXCR3
ligands. Given the complexity of HSV-2 genome which contains
over 70 genes (27, 28), we next investigated which viral
components are responsible for the induction of CXCR3 ligands
during HSV-2 infection. ME180 cells were co-transfected with
individual HSV-2 protein expression vector and the promoter
reporter of CXCL9, CXCL10, or CXCL11. Dual luciferase
reporter assay (DLR) indicated that HSV-2 immediate-early
protein ICP4 significantly activated the promoters of CXCR3
ligands (Figure 4A). The expression of all tested viral proteins
was assessed by Western Blot (Figure 4B). To further confirm
the role of ICP4 on transcriptional activation, ME180 cells were
transfected with ICP4 expressing plasmid, and cell supernatants
were collected for CBA while mRNAs were extracted for reverse
transcription PCR. Relative real-time quantitative PCR indicated
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FIGURE 2 | HSV-2 infection induces the production of CXCR3 ligands in human cervical epithelial cells. (A) HSV-2 infection activates the promoters of human CXCR3
ligands. ME180 cells in 24-well plates were co-transfected with 150 ng CXCL9-Luc, CXCL10-Luc or CXCL11-Luc, and 15 ng internal control plasmid phRL-TK. At 4 h
post-transfection, cells were infected with HSV-2 or ultraviolet-inactivated HSV-2 (UV-HSV-2) at an MOI of 1 for 24 h. DLR assay was performed. Values for the
samples were normalized using Renilla luciferase values and expressed as fold increase of the value induced in mock-infected samples. (B) HSV-2 infection induces
the mRNA production of CXCR3 ligands. ME180 cells in 6-well plates were infected with HSV-2 at an MOI of 1 for 24 h. Cells were harvested and total RNA was
extracted. The expression of CXCR3 ligands and GAPDH was evaluated by relative real-time quantitative PCR. The Ct values of GAPDH among all groups were
equable and not overloaded. mRNA copies of CXCR3 ligands were normalized using GAPDH and expressed as fold increase of the value for the mock-infected
control. (C) HSV-2 infection induces the production of CXCR3 ligands. As depicted in (B), cell supernatants were collected, and the protein level of CXCR3 ligands
was measured by CBA. Data shown are mean ± S.D. of three independent experiments (A, B, and C). *p < 0.05, **p < 0.01, ***p < 0.001.
that HSV-2 ICP4 enhanced the expression of CXCR3 ligands
at mRNA level (Figure 4C). CBA showed that HSV-2 ICP4
enhanced the production of CXCR3 ligands at protein level
(Figure 4D). Subsequent chemotaxis assay was performed to
assess the role of ICP4-induced CXCR3 ligands in promoting
the migration of activated PBMCs or CD4+ T cells. ME180
cells were transfected with ICP4 expressing plasmid, and the
chemotactic activity of supernatants was determined. In response
to supernatants from ICP4–transfected cells, the migratory
activity of PBMCs (Figure 4E) and CD4+ T cells (Figure 4F) was
significantly increased. Cell migration was significantly reduced
upon the addition of anti-CXCL9 (Figures 4E,F) neutralizing
Ab to supernatants from ICP4 expressing plasmid–transfected
cells or anti-CXCR3 neutralizing Ab (Figure 4G) to cell
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FIGURE 3 | HSV-2 infection-induced CXCL9 plays a predominant role in mediating CD4+ T cell migration. (A) The concentrations of CXCR3 ligands in the
supernatants of ME180 cells infected with HSV-2 or mock-infected with DMEM were detected by CBA. (B,C) CXCL9 induced by HSV-2 recruits the migration of
PBMCs (B) and CD4+ T cells (C). ME180 cells in 6-well plates were infected with HSV-2 at an MOI of 1 for 24 h. Cell supernatants were collected and added to the
lower chamber of transwell plates in the absence or presence of anti-CXCL9, –CXCL10, or/and –CXCL11 neutralizing Ab or control Ab for 1 h. (D) Neutralization of
CXCR3 reduces the migration of CD4+ T cells induced by HSV-2 infection. ME180 cells in 6-well plates were infected with HSV-2 at an MOI of 1 for 24 h. Cell
supernatants were collected and added to the lower chamber of transwell plates. The activated CD4+ T cells were incubated with RPMI 1,640 medium containing
anti-CXCR3 neutralizing Ab for 1 h and placed in the upper chamber. (E) Recombinant CXCL9 significantly induces the migration of CD4+ T cells. DMEM containing
recombinant CXCL9, CXCL10, or CXCL11 (48 pg/mL, 55 pg/mL and 175 pg/mL, respectively; the lowest concentration induced by HSV-2 infection) was added to
the lower chamber of transwell plates. (F,G) Recombinant CXCL10 or CXCL11 mediates the migration of CD4+ T cells in a dose-dependent manner. DMEM
containing recombinant CXCL10 or CXCL11 was added to the lower chamber of transwell plates. CXCL10 or CXCL11 was started from 55 pg/mL and 175 pg/mL,
respectively, at a concentration gradient of two times. The activated CD4+ T cells were placed in the upper chamber. After 2 h incubation, cells migrated to lower
chambers were collected and counted using an automatic cell counter. Cells migration was expressed as percentage of input. Input cells in the upper chamber were 5
× 105. Data shown are mean ± S.D. of three independent experiments (A–G). ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001.
suspension. In addition, the expression of CXCR3 in ICP4
expressing cells was also detected by flow cytometry assay,
showing that ICP4 did not induce the expression of CXCR3
(Supplementary Material Figure 5B). These results indicated
that the immediate-early protein ICP4 of HSV-2 promotes the
production of human CXCR3 ligands, of which CXCL9 plays a
predominant role in mediating CD4+ T cell migration.
HSV-2 ICP4 Regulates the Expression of
CXCR3 Ligands Via the p38 MAPK
Signaling Pathway
It is known that HSV-2 could activate MAPK pathway to
regulate the expression of downstream genes (29). Our previous
study demonstrated that HSV-2-mediated up-regulation of
CXCL9 involves the p38 MAPK signaling pathway (14). To
investigate whether MAPK pathway is involved in HSV-2-
mediated transcriptional activation of CXCL10 and CXCL11 or
ICP4-mediated transcriptional activation of CXCL9, CXCL10,
and CXCL11, ME180 cells were pretreated with or without
PD98059 (ERK inhibitor), SP600125 (JNK inhibitor) or
SB203580 (p38 inhibitor), and then transfected with CXCR3
ligand reporter plasmid followed by infection with HSV-2
or co-transfected with CXCR3 ligand reporter plasmid and
ICP4 expression plasmid. DLR assay showed that pretreatment
of cells with SB203580, but not with PD98059 or SP600125,
significantly decreased HSV-2–mediated activation of CXCL9
(Figure 5A), CXCL10 (Figure 5B), and CXCL11 (Figure 5C)
promoters. In accordance, ICP4–mediated activation of
CXCL9 (Figure 5D), CXCL10 (Figure 5E), and CXCL11
(Figure 5F) promoters was also decreased after pretreatment
with SB203580. In our previous study, we found that HSV-
2 infection could induce the phosphorylation of p38 and
CCAAT/enhancer-binding protein-β (C/EBP-β). We then
determined the impact of ICP4 on the activation of p38
MAPK pathway. ME180 cells were transfected with ICP4
expressing plasmid, and then the total or phosphorylation
level of p38 and the phosphorylation level of C/EBP-β were
examined by western blot assay. The results showed that,
like HSV-2, ICP4 increased the phosphorylation level of p38
(Figure 5G). Taken together, these results suggest that HSV-2
ICP4–induced CXCR3 ligand expression in human cervical
epithelial cells is mediated through the activation of p38 MAPK
pathway.
HSV-2 ICP4 Binds to the Promoters of
CXCR3 Ligands by Interaction With TBP
Although HSV-2 ICP4 induces the expression of CXCR3 ligands
via the p38 MAPK signaling pathway, it does not affect the
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FIGURE 4 | HSV-2 ICP4 promotes the production of human CXCR3 ligands. (A) ICP4 induces the activation of CXCR3 ligand promoters. ME180 cells in 24-well
plates were transfected with 300 ng expression plasmid of HSV-2 gene or empty vector together with 150 ng CXCR3 ligand reporter and 15 ng phRL-TK. At 24 h
post-transfection, DLR assay was performed. Values for the samples were normalized using Renilla luciferase values and expressed as fold increase of the value
induced in cells transfected with empty vector. (B) The expression of HSV-2 genes was detected using anti-Flag Ab by Western Blot. ME180 cells were transfected
with 3 µg HSV-2 gene expression plasmid for 24 h. The proteins were collected and detected using mouse anti-Flag Ab. (C) ICP4 induces the mRNA production of
CXCR3 ligands. ME180 cells in 6-well plates were transfected with 3 µg ICP4 expression plasmid for 24 h. Cells were harvested and total RNA was extracted. The
expression of CXCR3 ligands and GAPDH gene was evaluated by relative real-time quantitative PCR. The Ct values of GAPDH among all groups were equable and
not overloaded. mRNA copies of CXCR3 ligands were normalized using GAPDH and expressed as fold increase of the value for the empty vector-transfected control.
(D) ICP4 induces the production of CXCR3 ligands. As depicted in (C), cell supernatants were collected, and the protein levels of CXCR3 ligands were measured by
CBA. (E,F) CXCL9 induced by ICP4 recruits the migration of PBMCs (E) and CD4+ T cells (F). ME180 cells in 6-well plates were transfected with 3 µg ICP4
expression plasmid for 24 h. Cell supernatants were collected and added to the lower chamber of transwell plates in the absence or presence of anti-CXCL9,
–CXCL10, or/and –CXCL11 neutralizing Ab or control Ab for 1h. (G) Neutralization of CXCR3 reduces the migration of CD4+ T cells induced by ICP4. ME180 cells in
6-well plates were infected with HSV-2 at an MOI of 1 for 24 h. Cell supernatants were collected and added to the lower chamber of transwell plates. The activated
CD4+ T cells were incubated with RPMI 1,640 medium containing anti-CXCR3 neutralizing Ab for 1 h and placed in the upper chamber. As depicted in Figure 3, cells
migrated to lower chambers were counted. Cells migration was expressed as percentage of input. One representative out of three independent experiments is shown
(B). Data shown are mean ± S.D. of three independent experiments (A,C–G). ns, not significant, *p < 0.05, **p < 0.01, ***p < 0.001.
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FIGURE 5 | HSV-2 ICP4 regulates the expression of CXCR3 ligands via the p38 MAPK signaling pathway. (A–C) HSV-2 regulates the expression of CXCL9 (A),
CXCL10 (B), and CXCL11 (C) via p38/MAPK signaling pathway. ME180 cells in 24-well plates were co-transfected with 150 ng CXCR3 ligand reporter and 15 ng
phRL-TK. At 4 h post-transfection, cells were infected with HSV-2 at an MOI of 1 and supplemented with inhibitor PD98059, SP600125, or SB203580. DLR assay
was performed at 24 h post-transfection. Values for the samples were normalized using Renilla luciferase values and expressed as fold increase of the value induced in
mock-infected samples. (D–F) HSV-2 ICP4 regulates the expression of CXCL9 (D), CXCL10 (E), and CXCL11 (F) via p38/MAPK signaling pathway. ME180 cells in
24-well plates were co-transfected with 300 ng empty vector or ICP4 expression plasmid together with 150 ng CXCR3 ligand reporter and 15 ng phRL-TK. At 4 h
post-transfection, cells were cultured in complete DMEM supplemented with inhibitor PD98059, SP600125, or SB203580. DLR assay was performed at 24 h
post-transfection. Values for the samples were normalized using Renilla luciferase values and expressed as fold increase of the value induced in cells transfected with
empty vector. (G) ICP4 activates p38 MAPK signaling pathway. ME180 cells were transfected with 3 µg ICP4 expression plasmid. The protein level of p38,
phospho-p38 (p-p38) or phospho-C/EBP-β (p-C/EBP-β) was detected by Western Blot. Data shown are mean ± S.D. of three independent experiments (A–F). ns,
not significant, ***p < 0.001. One representative out of three independent experiments is shown (G).
phosphorylation level of C/EBP-β (Figure 5G), suggesting a
novel mechanism involved in ICP4-mediated production of
CXCR3 ligands. Previous studies have demonstrated that ICP4 is
essential for virus growth (30) and functions as a transcriptional
activator in some cases (31–34). It is probable that ICP4
binds to the promoters of CXCR3 ligands in the nucleus
which results in their transcriptional activation. ICP4 must be
located in the nucleus to act as a transcriptional factor. To test
this hypothesis, we first analyzed the nucleotide sequence of
ICP4, revealing several nuclear localization sequences (NLSs)
(Figure 6A). ME180 cells were transfected with HA-tagged
ICP4, and examined by indirect immunofluorescence (IF) and
western blot assay, showing that ICP4 was indeed located
in the nucleus (Figures 6B,C). In agreement, ICP4 was also
located in the nucleus in the context of HSV-2 infection
(Supplementary Material Figure 6). Meanwhile, at 24 h post-
transfection withHA-tagged ICP4,ME180 cells were collected for
chromatin immunoprecipitation (ChIP) assay. The ChIP assay
indicated that ICP4 bound to the promoters of CXCR3 ligands
(Figure 6D).
It is known that ICP4 can form a tripartite complex
with transcription factor II B (TFIIB) and either TBP or
transcription factor II D (TFIID) (35). TBP is required for
the initiation of transcription by RNA polymerases I, II, and
III, from promoters with or without a TATA box (36–38).
TBP associates with a host of factors to form multi-subunit
pre-initiation complexes on the core promoter. Through its
association with different transcription factors, TBP can initiate
transcription from different RNA polymerases (39). Considering
that ICP4 induces the phosphorylation of p38 (Figure 5G),
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FIGURE 6 | HSV-2 ICP4 binds to the promoters of CXCR3 ligands by interaction with TBP. (A) Schematic representation of the predicted NLSs of ICP4 amino acid
(AA) sequence. (B) ICP4 is located in the nucleus. ME180 cells in 35-mm dishes with glass bottom were transfected with 2 µg empty vector or HA-tagged ICP4
expression plasmid for 24 h. Cells were stained with mouse anti-HA mAb, followed by Cy3-conjugated goat anti-mouse (red) as the secondary Ab. Cell nuclei (blue)
were stained with DAPI. The images were obtained by fluorescence microscopy using 60× objective. The scale bar indicates 21µm. (C) The expression of ICP4 was
stained using anti-HA mAb. (D) ICP4 binds to the promoters of CXCR3 ligands. ME180 cells were transfected with 3 µg empty vector or HA-tagged ICP4 expression
plasmid for 24 h. Cells were lysed and subjected to ChIP assay using mouse anti-HA mAb, mouse anti-RNA polymerase II mAb (positive control) or mouse normal IgG
(negative control) for immunoprecipitation. (E) ICP4 interacts with TBP. ME180 cells in 6-well plates were transfected with 3 µg empty vector or HA-tagged ICP4
expression plasmid for 24 h. Cells were lysed and subjected to co-immunoprecipitation (IP) using rabbit anti-HA or anti-TBP Ab. Rabbit normal IgG was used as a
negative control. IP products and 5% input samples were examined using rabbit anti-HA and rabbit anti-TBP Abs by western blot. One representative out of three
independent experiments is shown (B–E).
and that the transcriptional activation of TBP requires the
activation of p38 MAPK signaling pathway (40, 41), ICP4-
induced activation of p38 likely contributes to the transcriptional
activation of TBP. To verify the interaction of ICP4 with
TBP, ME180 cells were transfected with HA-tagged ICP4 for
24 h. Co-immunoprecipitation assays were performed to detect
the interaction of ICP4 with TBP. The results indicated that
ICP4 interacts with TBP as evidenced by using an anti-HA
antibody to pulldown TBP or an anti-TBP antibody to pulldown
ICP4 (Figure 6E). These data collectively indicated that HSV-2
ICP4 binds to the promoters of CXCR3 ligands by interaction
with TBP, leading to the promoter activation of CXCR3
ligands.
DISCUSSION
Recruitment of CD4+ T cells, irrespective of their specificity,
may significantly increase the chance of HIV-1 transmission
(42, 43). Our previous study found that CXCL9 levels in
cervical mucus from HSV-2–positive women were significantly
increased and that HSV-2 infection induced CXCL9 expression
in cervical epithelial cells (14). In addition, the expression of
CXCL9 and CXCL10 was shown to be increased in the cervical
tissues of mice infected by HSV-2 in studies to understand the
contribution of recruited CD8+ T cells in control of HSV-2
infection (20), while CXCL9 induced by HSV-1 infection has
been shown to recruit CD4+ T cells into the cornea (26).
Moreover, circulating memory CD4+ T cells could migrate to the
genital mucosa in mice challenged with HSV-2 (44). However,
how HSV-2 infection affects the migration of CD4+ T cells at
mucosal sites and the biological consequences remain to be fully
determined.
In this study, we observed that, following vaginal challenge
with HSV-2, mouse CXCR3 ligands CXCL9, CXCL10, and
CXCL11 were all upregulated in the vaginal fluids of infected
mice. In addition, CD4+ T cells migrated to the vaginal foci of
infectedmice, while the number of CD4+ T cells was significantly
decreased after administration of CXCL9 neutralizing antibody
to the vagina of mice. These indicate that HSV-2 infection can
promote CD4+ T cell migration and this is mainly due to the
induced CXCL9 expression. Although HSV-2 infection likely
induces the expression of many other chemokines, our results
showed that the migration of CD4+ T cells was significantly
reduced after administration of a combination of neutralizing
Abs against CXCL9, CXCL10, and CXCL11 into the vaginal
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tissue. In human cervical epithelial cells, we demonstrated that
HSV-2 infection induced not only the production of CXCL9 but
also that of CXCL10 and CXCL11. The common receptor for
CXCL9, CXCL10, and CXCL11 is CXCR3, which can be rapidly
induced on activated naive cells and sustain high level expression
on Th1-type CD4+ T cells and effector CD8+ T cells (15). The
other two ligands of CXCR3, CXCL4, and CXCL4L1, are released
by platelets and have been implicated in atherogenesis and acute
coronary syndrome (16). Therefore, we mainly focused on how
HSV-2 infection enhances the production of CXCR3 ligands
CXCL9, CXCL10, and CXCL11.
Early studies on transmitted/founder (T/F) HIV-1 have
suggested that CD4+ T cells serve as the main target cells in
the establishment of HIV-1 early infection (9, 45). Although
CXCR3 ligands induced by HSV-2 can activate and recruit CD8+
T cells, these cells are specific for HSV-2 and may have an
impact on the control of HSV-2 replication (20, 46, 47). In
the current study, we mainly assessed the biological function
of CXCR3 ligands induced by HSV-2 on CD4+ T recruitment.
We found that chemokines induced by HSV-2 can mediate
the migration of CD4+ T cells. Following experiments using
neutralizing antibodies, the results indicated that the induced
CXCL9 plays a crucial role in recruiting CD4+ T cells, which
was further confirmed by using recombinant CXCL9, CXCL10,
or CXCL11 at a concentration similar to that induced by HSV-2.
Chemokines CXCL10 and CXCL11 at the concentrations around
or higher than 300 pg/mL and 350 pg/mL, respectively, have
been shown to have chemotactic activity for CXCR3+ cells (48–
50), whereas CXCL9 has the same capability at a much lower
concentration (14).We did not see significant reduction of CD4+
T cell migration when CXCL10 or CXCL11 was neutralized
by the corresponding neutralizing antibody. One reasonable
explanation is that the concentrations of CXCL10 and CXCL11
required for CD4+ T cell migration are much higher than that
of CXCL9. In our study, the concentrations of CXCL10 and
CXCL11 induced by ICP4 or HSV-2 were around or lower than
55 pg/mL and 175 pg/mL, respectively, which was unable to
have an impact on CD4+ T cell migration as evidenced by
the chemotaxis assay using recombinant CXCL10 and CXCL11.
The recombinant CXCL10 at the concentration of 55 pg/mL
had a marginal effect on CD4+ T cell migration, whereas the
recombinant CXCL11 at the concentration of 175 pg/mL had no
effect on the recruitment of CD4+ T cell. Compared to those
induced by HSV-2 or ICP4, recombinant CXCL10 and CXCL11
at much higher concentrations chemotracted CD4+ T cells in
a dose-dependent manner. Although beyond the scope of this
current study, it will be important to address the roles of CXCR3
ligands in mediating CD4+ T cell migration and HIV-1 mucosal
transmission when an animal model become available to study
HSV-2 and HIV-1 co-infection.
We found that UV-inactivated HSV-2 did not significantly
induce the transcriptional activation of CXCL9 and CXCL10.
Although CXCL11 appeared to be induced by UV-inactivated
HSV-2, the level of induction was low. These results indicate
that productive infection of HSV-2 is essential for the induced
production of CXCR3 ligands. HSV-2 genome contains over 70
genes (27, 28). Following screening a range of HSV-2 ORFs,
we identified the immediate-early protein ICP4 as the key
viral component in inducing the expression of CXCR3 ligands.
ICP4 was barely detectable when cells were treated with UV-
inactivated HSV-2, further suggesting the importance of ICP4 in
inducing CXCR3 ligand expression. In agreement, we observed
the co-localization of ICP4 with CXCL9, CXCL10 or CXCL11
in the mouse vaginal epithelial layer by immunofluorescence
histochemistry assay (Supplementary Material Figure 8). ICP4-
induced CXCL9 played a crucial role in the chemotaxis of
CD4+ T cells, which is in accordance with that induced by
HSV-2. We previously found that HSV-2 infection-induced
CXCL9 expression is regulated by the transcriptional factor
C/EBP-β (14). In the current study, we found that ICP4 did
not affect the phosphorylation of C/EBP-β, although ICP4
induced the production of all the three CXCR3 ligands via
p38 MAPK signaling pathway. These together indicate a novel
mechanism underlying ICP4-induced CXCR3 ligand production,
and that other viral component(s) is likely to be involved in the
phosphorylation of C/EBP-β. It is known that ICP4 is a major
transcriptional activator and essential for progression beyond the
immediate-early phase of infection (28). Indeed, we successfully
constructed a ICP4-null HSV-2 bacterial artificial chromosome
(BAC) but were unable to rescue the ICP4-null HSV-2 (data
not shown), further strengthening the essential role of ICP4 in
the regulation of viral gene expression. ICP4 can function as a
transcriptional activator in some cases (31–34). It may act as
a transcriptional activator to induce the activation of CXCR3
ligand promoter. To function as a transcriptional factor, ICP4
needs to be in the nucleus where it can bind to the promoters
of CXCR3 ligands. We found that ICP4 is indeed located in
the nucleus and can bind to the promoters of CXCR3 ligands,
resulting in the expression of corresponding chemokines. ICP4
was also located in the nucleus in the context of HSV-2 infection.
We also observed the interaction of ICP4 with TBP, which could
contribute to the binding of ICP4 to the promoters of CXCR3
ligands. Nevertheless, ICP4 seems not to serve as a consensus
transcription factor to activate gene expression, as ICP4 did not
activate the promoters of other cytokines including TNF, IL-6
(Supplementary Material Figure 7).
In conclusion, we first found that the expression of CXCR3
ligands CXCL9, CXCL10, and CXCL11 was induced following
mice vaginally challenged with HSV-2, which was associated with
the increased number of CD4+ T cells in the vaginal foci of
infected mice as well as CXCL9-mediated cell migration. We
further observed that HSV-2 infection induced the production
of CXCL10 and CXCL11 in addition to CXCL9 in human
cervical epithelial cells. Although CXCL10 and CXCL11 could
be induced by HSV-2, HSV-2-induced CXCL9 played a critical
role in recruitment of CD4+ T cells. Mechanistically, after
identifying HSV-2 ICP4 as a vital viral component in inducing
CXCR3 ligands, we demonstrated the contribution of ICP4-
induced CXCL9 in recruiting CD4+ T cells and a critical role
played by p38 MAPK signaling pathway in HSV-2 infection- or
ICP4–induced CXCR3 ligand expression. HSV-2 ICP4 binds to
the corresponding promoters of CXCR3 ligands by interaction
with TBP to activate their transcription. Our study together
reveals the molecular mechanism underlying HSV-2-induced
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CD4+ T cell accumulation in mucosal infection sites, which
may be crucial for understanding HSV-2 infection-enhanced
HIV-1 sexual transmission and the development of intervention
strategies.
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